NAPLEX (North American Pharmacist Licensure Examination) Practice Exam

Disable ads (and more) with a membership for a one time $2.99 payment

Prepare to ace the NAPLEX. Utilize flashcards and multiple choice questions with hints and explanations. Equip yourself thoroughly for the exam!

Each practice test/flash card set has 50 randomly selected questions from a bank of over 500. You'll get a new set of questions each time!

Practice this question and more.

What is the risk associated with using estrogen-containing products in women over 35 who smoke?

Risk of osteoporosis
Risk of heavy menstrual bleeding
Risk of serious cardiovascular events
No associated risks

The correct answer is: Risk of serious cardiovascular events

Using estrogen-containing products in women over 35 who smoke poses a significant risk of serious cardiovascular events. Smoking combined with estrogen can increase the risk of blood clots, stroke, heart attack, and other cardiovascular complications. Estrogen itself can also impact the cardiovascular system by affecting blood clotting factors and increasing the risk of thromboembolic events. Therefore, it is crucial to caution against the use of estrogen-containing products in this specific population due to the elevated risk of serious cardiovascular events. Options A (risk of osteoporosis) and B (risk of heavy menstrual bleeding) are not directly associated with the use of estrogen-containing products in women over 35 who smoke. Option D (No associated risks) is incorrect as there are indeed risks associated with using estrogen-containing products in this population, particularly related to cardiovascular health.